These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6866 related items for PubMed ID: 18018602

  • 1. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 3. [Clinical application of testing methods on acid-fast bacteria].
    Ichiyama S, Suzuki K.
    Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 6. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T, Iwamoto T.
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [Abstract] [Full Text] [Related]

  • 7. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A.
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [Abstract] [Full Text] [Related]

  • 8. [Exogenous re-infection in tuberculosis].
    Tsuchiya T.
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [Abstract] [Full Text] [Related]

  • 9. [New era in molecular epidemiology of tuberculosis in Japan].
    Takashima T, Iwamoto T.
    Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
    [Abstract] [Full Text] [Related]

  • 10. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 11. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K, Sano C.
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [Abstract] [Full Text] [Related]

  • 12. A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M.
    Procedia Vaccinol; 2010 Mar; 2(1):34-39. PubMed ID: 32288910
    [Abstract] [Full Text] [Related]

  • 13. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
    Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Hum Vaccin; 2011 Mar; 7 Suppl():108-14. PubMed ID: 21263229
    [Abstract] [Full Text] [Related]

  • 14. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H.
    Curr Pharm Des; 2014 Mar; 20(27):4305-6. PubMed ID: 24245755
    [Abstract] [Full Text] [Related]

  • 15. [Prospects for development of new antituberculous drugs].
    Tomioka H.
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M.
    Vaccine; 2007 Apr 20; 25(16):2990-3. PubMed ID: 17280753
    [Abstract] [Full Text] [Related]

  • 17. [Genetic research about Mycobacterium avium complex].
    Ogawa K.
    Kekkaku; 2011 Feb 20; 86(2):61-8. PubMed ID: 21404652
    [Abstract] [Full Text] [Related]

  • 18. A Novel Therapeutic and Prophylactic Vaccine against Tuberculosis Using the Cynomolgus Monkey Model and Mouse Model.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Kaneda Y, Saunderson P, Tan EV, McMurray DN.
    Procedia Vaccinol; 2011 Feb 20; 4():42-49. PubMed ID: 32288912
    [Abstract] [Full Text] [Related]

  • 19. [The development of novel vaccines against tuberculosis].
    Okada M.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct 20; 31(5):356-68. PubMed ID: 18974619
    [Abstract] [Full Text] [Related]

  • 20. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
    Okada M, Kita Y, Hashimoto S, Nakatani H, Nishimastu S, Kioka Y, Takami Y.
    Hum Vaccin Immunother; 2017 Feb 20; 13(2):298-305. PubMed ID: 27960629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 344.